Literature DB >> 8786079

The gene for X-linked hypophosphataemic rickets maps to a 200-300kb region in Xp22.1, and is located on a single YAC containing a putative vitamin D response element (VDRE).

P S Rowe1, J N Goulding, F Francis, C Oudet, M J Econs, A Hanauer, H Lehrach, A P Read, R C Mountford, T Summerfield, J Weissenbach, W Fraser, M K Drezner, K E Davies, J L O'Riordan.   

Abstract

The location of the HYP gene, which determines X-linked hypophosphataemic rickets, has been refined considerably by linkage analysis, and three new microsatellite primers isolated, Cap32 (DXS7473), Cap29 (DXS7474) and 7v2 (DXS7475). The locations of four other markers have also been determined (DXS1226, AFMa176zb1, AFMa152wc5, and AFM346azc1). Markers Cap29 and Cap32 are the closest distal markers to the gene with zetamax=11.93, thetamax= 0.018 and zetamax=12.03, thetamax = 0.015 respectively. Both Cap29 and Cap32 are proximal to DXS365 and AFMa176zb1, as deduced by screening non-chimaeric yeast artificial chromosomes (YACs) from a contig spanning the HYP gene. A single crossover places AFMa176zbl distal to the disease gene. There are no recombinations between 7v2 and HYP (zetamax=12.9, thetamax=0.0), or between 7v2 and adjacent markers Cap32, Cap29, AFMa176zb1, DXS1683 and DXS365. However screening of YAC clones encompassing the HYP gene and also P1 clones localises 7v2 distal to Cap29 and Cap32, and proximal to DXS443. Marker DXS1226 is placed outside the region containing the gene, and is located proximal to DXS274 as confirmed by a crossover for this marker and DXS41 against HYP and its presence on YAC 83B05. Genetic mapping of CEPH pedigrees, and screening of YACs places AFMa152wc5 and AFMa346zcl between DXS1683 and DXS1052. The following gene marker map presents the best order for the HYP region: Xptel-DXS43-DXS999-DXS443-(DXS365/DXS74 75/AFMa176zb1)-(DXS7474/DXS7473)-HYP- DXS1683-(AFMa152wc5/AFMa346zc1)-DXS1052-DXS 274 -(DXS41/DXS1226)-Xcen. The distance between the cluster of distal flanking markers Cap29 (DXS7474), Cap32 (DXS7473), and DXS1683 is approximately 300 kb, as deduced from physical map data from a YAC contig spanning the gene. Thus the gene for HYP is contained within a single YAC (900AO472). Of further interest, is the location of a putative vitamin D response element (VDRE) on this YAC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786079     DOI: 10.1007/bf02185769

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  36 in total

1.  VITAMIN D-RESISTANT RICKETS. ANALYSIS OF TWENTY-FOUR PEDIGREES WITH HEREDITARY AND SPORADIC CASES.

Authors:  C H BURNETT; C E DENT; C HARPER; B J WARLAND
Journal:  Am J Med       Date:  1964-02       Impact factor: 4.965

2.  Yeast artificial chromosome libraries containing large inserts from mouse and human DNA.

Authors:  Z Larin; A P Monaco; H Lehrach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Positional cloning: let's not call it reverse anymore.

Authors:  F S Collins
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

4.  Micropuncture study of renal phosphorus transport in hypophosphatemic vitamin D resistant rickets mice.

Authors:  S D Giasson; M G Brunette; G Danan; N Vigneault; S Carriere
Journal:  Pflugers Arch       Date:  1977-10-19       Impact factor: 3.657

Review 5.  Side-chain hydroxylation of vitamin D3 and its physiological implications.

Authors:  G Jones; D Vriezen; D Lohnes; V Palda; N S Edwards
Journal:  Steroids       Date:  1987 Jan-Mar       Impact factor: 2.668

6.  Bridging markers defining the map position of X linked hypophosphataemic rickets.

Authors:  R V Thakker; A P Read; K E Davies; M P Whyte; R Weksberg; F Glorieux; M Davies; R C Mountford; R Harris; A King
Journal:  J Med Genet       Date:  1987-12       Impact factor: 6.318

7.  Binding of the receptor for 1,25-dihydroxyvitamin D3 to the 5'-flanking region of the bovine parathyroid hormone gene.

Authors:  S M Farrow; N S Hawa; R Karmali; M Hewison; J C Walters; J L O'Riordan
Journal:  J Endocrinol       Date:  1990-09       Impact factor: 4.286

8.  Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis.

Authors:  A P Read; R V Thakker; K E Davies; R C Mountford; D P Brenton; M Davies; F Glorieux; R Harris; G N Hendy; A King
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Y Ohyama; M Noshiro; G Eggertsen; O Gotoh; Y Kato; I Björkhem; K Okuda
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

View more
  16 in total

Review 1.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

Authors:  Cassianne Robinson-Cohen; Traci M Bartz; Dongbing Lai; T Alp Ikizler; Munro Peacock; Erik A Imel; Erin D Michos; Tatiana M Foroud; Kristina Akesson; Kent D Taylor; Linnea Malmgren; Kunihiro Matsushita; Maria Nethander; Joel Eriksson; Claes Ohlsson; Daniel Mellström; Myles Wolf; Osten Ljunggren; Fiona McGuigan; Jerome I Rotter; Magnus Karlsson; Michael J Econs; Joachim H Ix; Pamela L Lutsey; Bruce M Psaty; Ian H de Boer; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2018-09-14       Impact factor: 10.121

Review 3.  Mutation watch: PEX PLUS? Gene(s) for X-linked hypophosphatemia and deafness.

Authors:  M Meisler
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

4.  Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.

Authors:  Doron Bresler; Jan Bruder; Klaus Mohnike; William D Fraser; Peter S N Rowe
Journal:  J Endocrinol       Date:  2004-12       Impact factor: 4.286

5.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

6.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

Review 7.  Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

Authors:  Peter S N Rowe
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

Review 8.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

Review 9.  Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

Authors:  Jian Q Feng; Erica L Clinkenbeard; Baozhi Yuan; Kenneth E White; Marc K Drezner
Journal:  Bone       Date:  2013-02-09       Impact factor: 4.398

10.  MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Authors:  P S N Rowe; Y Kumagai; G Gutierrez; I R Garrett; R Blacher; D Rosen; J Cundy; S Navvab; D Chen; M K Drezner; L D Quarles; G R Mundy
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.